A systematic review of commercial weight loss programmes' effect on glycemic outcomes among overweight and obese adults with and without type 2 diabetes mellitus.
Z W ChaudhryR S DoshiA K MehtaD K JacobsR M VakilA Richey SharrettS N BleichR R KalyaniJ M ClarkK A GudzunePublished in: Obesity reviews : an official journal of the International Association for the Study of Obesity (2016)
Few trials have examined whether commercial weight loss programmes result in glycemic benefits for their participants, particularly among overweight and obese individuals without T2DM. Jenny Craig, Nutrisystem and OPTIFAST show promising glycemic lowering benefits for patients with T2DM, although additional studies are needed to confirm these conclusions. © 2016 World Obesity.